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ABSTRACT Using x-ray diffraction and mechanical stiffness, the response of N-phenylmaleimide (NPM)-reacted cross-
bridges to solutions containing different amounts of ATP and Mg2 has been studied. In relaxing solution containing greater
than millimolar amounts of ATP and Mg2, NPM-treated muscle fibers give x-ray diffraction patterns and stiffness records,
which are nearly indistinguishable from those of untreated relaxed fibers. In a solution devoid of added ATP, but with Mg2
(rigor(Mg) solution), the muscle fibers still give x-ray diffraction patterns and mechanical responses characteristic of relaxed
muscle. The new finding reported here is that in a solution devoid of both ATP and Mg2 (rigor(Mg) solution containing EDTA
with no added ATP), NPM-reacted cross-bridges do give rigor-like behavior. This is the first report that NPM-reacted
cross-bridges, at least in the presence of EDTA, are capable of going into a strongly binding conformation.
INTRODUCTION
Chaen et al. (1986) reported that muscle fibers reacted with
para-phenylenedimaleimide (pPDM) do not produce force.
This was confirmed by Barnett et al. (1992) who also found,
in agreement with solution studies on pPDM-treated myosin
subfragment-1 (Greene et al., 1986), that pPDM-reacted
cross-bridges are locked in a weakly binding conformation
and do not go into a strongly binding conformation either in
the presence of MgATP and calcium or in the absence of
ATP. This led to the conclusion that pPDM reaction pre-
vented force production by locking cross-bridges in a
weakly binding conformation.
Barnett et al. (1992) also reported that a muscle fiber
treated in relaxing solution for 1 h with 100 M N-phenyl-
maleimide (NPM) similarly produces zero force in response
to calcium stimulation and does not go into a strongly
binding or rigor-like conformation in the presence of cal-
cium and ATP or in the absence of ATP. Thus, it was
postulated that NPM modification, which, like pPDM-mod-
ification, links maleimide groups to SH1 and SH2 (Burke
and Knight, 1980; Huston et al., 1988; Ehrlich et al., 1995),
also inhibits force by locking the cross-bridges in a weakly
binding conformation.
Although the previous data suggest that the mechanism
by which NPM and pPDM inhibit force is similar, here we
show that cross-bridges in NPM-reacted muscle fibers in-
deed go into a strongly binding conformation in magne-
sium-free rigor solution.
METHODS
Muscle preparation and solutions
All experiments were performed on chemically skinned muscle of the
rabbit psoas major. Small bundles, 0.3  0.6 mm in cross section and 30
mm in length, were used for the x-ray diffraction experiments (Xu et al.,
1997), and single fiber segments, 0.1 mm in diameter and 10 mm long,
were used for the stiffness measurements (Schoenberg, 1988). The sar-
comere length of both the bundles and fibers were determined by light
diffraction and adjusted to 2.5 m. The specimen chambers were cooled to
4 1°C, and for the bundles, the solution in the chamber was continuously
stirred by a syringe pump at the rate of 1 ml/s to minimize any gradients
along the length of the fibers.
Relaxing solution contained 2 mM MgATP, 2 mM MgCl2, 2 mM
EGTA, 2 mM dithiothreitol (DTT), 48 mM creatine phosphate, and 10 mM
imidazole. Magnesium-free rigor solution, rigor(Mg), contained 2.5 mM
EGTA, 2.5 mM EDTA, 150 mM KPropionate, and 10 mM imidazole.
Magnesium-containing rigor solution, rigor(Mg), contained 2.5 mM
EGTA, 2 mM MgCl2, 152 mM KPropionate, and 10 mM imidazole.
Quick-rinse solution, used when changing from relaxing to rigor solution,
contained 5 mM EGTA, 15 mM EDTA, and 20 mM imidazole. NPM-
treatment solution contained 0.1 mM N-phenylmaleimide, 4 mM EGTA, 1
mM MgCl2, 4 mM MgATP, 125 mM KCl, and 10 mM imidazole. The pH
of all the solutions was 7.0  0.05. The ionic strength of all the solutions
was 170 mM except for the quick-rinse solution that had an ionic
strength of 70 mM. All solutions except NPM-treatment solution con-
tained 0.5 mM dithiothreitol.
X-ray camera and imaging plate detector system
X-ray experiments were performed using a rotating anode x-ray generator
(Elliot GX-6) at power 35 kV  35 mA. The x-ray beam was focused by
two gold-coated mirrors. Specimen to detector distance was 89 cm. The
two-dimensional x-ray patterns were recorded on an imaging plate detector
system (MAR Research, Hamburg, Germany) with 50  50-m pixels.
The scanned area was 10 cm in diameter. To compare directly the inten-
sities obtained under different conditions with minimum error, diffraction
patterns always were recorded from the same bundle for all the conditions
of interest.
Experimental protocols
Treatment
Bundles or single fibers were treated with 0.1 mM NPM for 1 h; the
reaction was terminated by replacing the NPM-treatment solution with
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relaxing solution that contained DTT. Before going into rigor(Mg) so-
lution or rigor(Mg) solution, the bundles or fibers first were incubated in
quick-rinse solution for 5 min.
X-ray diffraction
The exposure time for each pattern was 1 h. The data were displayed and
analyzed on a Silicon Graphics Indigo workstation (Mountain View, CA)
using a program, Profida, originally written by M. Lorenz (Max Plank
Institute, Heidelberg, Germany) and modified by D. Gilroy (National
Institutes of Health, Bethesda, MD). The patterns of the original data were
first rotated and translated. Then the data in the four quadrants were added
(folded) and averaged. Measuring the integrated intensities of interest, two
kinds of slices on the patterns were made: a horizontal slice along the
equator with a width covering the whole equatorial reflection area and a
vertical slice crossing the first actin layer line at the peak of the reflection
(width shown by dashed lines in Fig. 4 C). All values of integrated
intensities were normalized by the equatorial 11 reflection, setting I11 for
the muscle in rigor(Mg) solution at 100.
RESULTS
Fig. 1 shows the effect of NPM treatment on the behavior of
rabbit psoas fibers in relaxing solution. NPM treatment has
very little effect on either the structure or mechanical prop-
erties of a muscle fiber in relaxing solution. The whole x-ray
diffraction patterns of the muscle bundle after NPM treat-
ment are nearly identical to those before (compare Fig. 1, A
and B). The equatorial I11/I10 ratio increases by only10%,
and more importantly, there are no differences in the inten-
sity and spacings of the first order layer lines (see Fig. 3 A).
The apparent stiffness in response to rapid stretch similarly
remains relaxed-like after treatment (Fig. 1, C), as reported
previously (Barnett et al., 1992).
In rigor solution containing no ATP but having 2 mMMg
(rigor(Mg) solution), NPM-treated fibers retain the char-
acteristics of relaxed muscle (Fig. 2). The relaxed x-ray
pattern persists for as much as 11 h after treatment (Fig. 3
A). Only a very slight drift toward rigor is seen in the I11/I10
ratio and the 2-D pattern. Although the drift in the I11/I10
ratio and the 2-D pattern is small, it is none the less
somewhat larger than that seen in a treated or untreated fiber
exposed to the same dose of x-rays in relaxing solution. It
should be pointed out that the mechanical response also,
although slightly increased, remains relaxed-like for many
hours after treatment (Fig. 3 B).
In contrast to the above behavior, in a solution in which
ATP and Mg both are absent (rigor(Mg) solution), fibers
in a muscle bundle go into a rigor-like state within just a few
hours (Fig. 4 A). The single fiber preparation develops full
rigor stiffness even more quickly, within 30 min, as seen in
Fig. 4 B. The time course of rigor development in a muscle
bundle presumably is limited by slower diffusion of mole-
cules into and out of the thicker preparation. Fig. 4 C shows
the 2-D x-ray pattern 3 h after removal of Mg2. After 3 h
in rigor(Mg) solution, the pattern shows changes that are
typical of the transition to rigor. The I11/I10 ratio increases
from 1.39  0.05 to 2.46  0.08. In parallel, the intensity
of the first order layer line increases from 0.40  0.03 to
2.47  0.49. Finally, the spacing of the first layer line
changes from close to 43 nm (myosin-based) to close to
36.5 nm (actin-based).
The rigor condition induced in the NPM-treated fibers by
removal of Mg2 and ATP is rapidly reversed upon the
addition of MgATP as shown in Fig. 5 A, and the mechan-
ical stiffness returns within minutes to the same value as
before removal (Fig. 5 B). Just as initially, removal of Mg2
and ATP a second time again leads to development of a
rigor-like state, and removal of ATP alone results in the
cross-bridges remaining weakly binding (data not shown).
The data suggest that the cross-bridges that go into a rigor-
like state upon Mg2 removal are not in a denatured irre-
versible state but are in a state that is capable of binding
MgATP when it is reintroduced to the solution.
DISCUSSION
Although elucidation of the molecular structure of actin and
myosin has shed much light on the mechanism of force
production by muscle, many questions remain concerning
the role of myosin’s two essential sulfhydryls, SH1 (Cys-
707) and SH2 (Cys-697). These two sulfhydryls, which can
be alkylated by a variety of compounds, have been revealed
to be situated close to the bottom of the nucleotide binding
pocket and also the bottom of the cleft thought important for
actin binding (Rayment et al., 1993). Whereas there is good
agreement that reaction of both sulfhydryls by a variety of
compounds results in the loss of the ability of myosin to
hydrolyze ATP and make force (Yamaguchi and Sekine, 1966;
Reisler et al., 1974; Chaen et al., 1986; Ehrlich et al., 1995),
there is surprisingly considerable disagreement whether inhi-
bition of force production occurs with reaction solely at SH1 or
solely at SH2 (Crowder and Cooke, 1984; Root et al., 1991).
Two of the many compounds that react with SH1 and
SH2 are pPDM and NPM. Both inhibit force production,
and both, for the treatment conditions generally used, alky-
late both SH1 and SH2 (Barnett et al., 1992; Ehrlich et al.,
1995). pPDM is a bifunctional reagent with two reactive
maleimide rings, and it would likely prove difficult to limit
its reaction to just one of the sulfhydryls. However, NPM
has but a single reactive ring and should with a slight modifi-
cation of the standard reacting protocol be capable of reacting
with either solely SH1 (Xie et al., 1997) or solely SH2 (Reisler
et al., 1974). This, in turn, should provide information on
whether the effects attributable to alkylation of myosin’s sulf-
hydryls are because of alkylation of just one or the other or
whether the effects require alkylation of both sulfhydryls.
It is known that treatment of muscle fibers with para-
phenylenedimaleimide locks cross-bridges in a weakly
binding state, a finding that in and of itself is sufficient to
explain the ability of pPDM-treatment to inhibit force pro-
duction in muscle fibers (Chaen et al., 1986; Barnett et al.,
1992). Previous evidence suggested that N-phenylmaleim-
ide acts similarly. Like pPDM, it also has been reported to
inhibit force production and lock the cross-bridges in a
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weakly binding state (Barnett et al., 1992). The data in this
paper, however, suggest that in Mg-free rigor solution
NPM-treated cross-bridges clearly go into a strongly bind-
ing rigor-like state characterized by a rigor-like 2-D x-ray
diffraction pattern (Fig. 4 C) and a stiffness the same as that
of a rigor fiber. The data here present the first evidence that
NPM-treated cross-bridges are not always locked in a
weakly binding state and further suggest that magnesium is
treatment; (B) same bundle in the same ATP solution immediately after 1 h
of NPM treatment; (C) effect of NPM treatment on the stiffness of a single
fiber in ATP-relaxing solution. Curves before (solid line) and after (dotted
line) are nearly indistinguishable.
FIGURE 1 X-ray diffraction patterns (A and B) and stiffness measure-
ments (C) of NPM-treated muscle. (A) ATP-relaxed bundle before NPM
FIGURE 2 (A) X-ray diffraction pattern from NPM-treated fiber bundle
in relaxing solution. (B) Diffraction pattern of same fiber in rigor(Mg)
solution. This fiber bundle is different from the one shown in Fig. 1.
Classic relaxed features are present in both.
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an important ion in determining if the cross-bridge can go
into a strongly binding conformation. It is not clear from
these studies how magnesium is preventing cross-bridges
from going into a strongly binding conformation in rigor
solution or even where magnesium is acting. There are
several possibilities with regard to this latter question.
One site at which magnesium has a direct effect is the
high-affinity site of troponin. Magnesium binding to the
high-affinity site in the absence of calcium is important for
maintaining the structural integrity of troponin. In the ab-
sence of calcium or magnesium, the troponin C subunit
tends to dissociate from the troponin complex, particularly
at lower ionic strength (Zot and Potter, 1982). Although it is
not at all clear that such a phenomenon would occur under
the ionic strength conditions of our experiment, this finding
does raise the possibility that the magnesium effect is be-
cause of magnesium binding to the high-affinity Ca2/
Mg2 site of troponin.
FIGURE 4 Quantitation and time course of rigor development in the
absence of Mg. (A) Integrated intensity of the first layer line (left coordi-
nate) and the I11/I10 (right coordinate) as a function of time. Value of
integrated intensity is normalized by I11 of the muscle in rigor(Mg).
NPM treatment started at time  0. Rigor (Mg) solution was introduced
at time  2 hours. (B) Time course of stiffness development in a single
fiber upon removing Mg. (C) 2-D X-ray diffraction pattern after 3 hours in
rigor (Mg) solution (same fiber as in Fig. 1).
FIGURE 3 (A) Quantitation of x-ray patterns of small NPM-reacted
muscle bundles in relaxing and in rigor(Mg) solution; (B) typical stiff-
ness measurements from a single fiber in ATP-relaxing and rigor(Mg)
solution. The mechanical response in rigor(Mg) solution (dotted line) is
only slightly larger than the response in relaxing solution (solid line).
Xu et al. Strongly Binding NPM-Reacted Cross-Bridges 1113
A second site that magnesium binds to directly is the
regulatory light chain of myosin. Divalent cation binding to
the regulatory light chain is thought to affect the rate con-
stants of force development in skeletal muscle fibers (Diffee
et al., 1996). It is difficult to understand, however, how this
would account for the results reported here.
The most important role for magnesium is as the divalent
cation bound to ATP. Free ATP without magnesium is not
a good substrate for force production and does not relax
skeletal muscle (Rizzino et al., 1970; Cooke and Franks,
1980). This raises the possibility that the relaxing effect of
Mg2 reported here is not because of Mg2 binding directly
to a protein, but because of binding to cation-free ATP
trapped at the nucleotide binding site of myosin.
Regardless of the site of action of magnesium, it is interest-
ing that, contrary to previously published results (Barnett et al.,
1992), NPM-reacted cross-bridges can go into a strongly bind-
ing conformation, at least under the condition of 0 Mg2.
Whether elimination of Mg2 from all the sites discussed
above is necessary for this to occur, remains to be seen.
The data suggest that NPM-reacted cross-bridges can
undergo the weakly to strongly binding conformational
change and that the nucleotide driven weakly to strongly
binding conformational change in the contractile cycle is a
step distinct from the hydrolysis step. For NPM-reacted
cross-bridges, hydrolysis is greatly reduced but the weakly
to strongly binding transition can still occur.
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FIGURE 5 Addition of MgATP after development of rigor brings the
muscle back to its initial relaxed state. (A) X-ray diffraction data; (B)
stiffness measurement.
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